Illustration of an icosahedral viral capsid connected to DNA electrophoresis bands

Biomedical science — oncovirology

Dr. Julio César Osorio Patiño, PhD

PhD in Biomedical Sciences · Head of the Department of Basic Sciences — UNICOC, Cali

I study how oncogenic viruses —HPV and MMTV-like viruses— take part in cancer development, from tissue to biomarker.

View services Publications Book a consultation

Oncovirus

The viruses that can cause cancer — and can be prevented

An oncovirus is a virus capable of triggering cancer. IARC-WHO recognizes HPV, Epstein-Barr virus, the hepatitis B and C viruses, HTLV-1, KSHV (HHV-8) and Merkel cell polyomavirus as human carcinogens. Knowing them is the first step to preventing and detecting them in time.

HPV
EBV
HBV
HCV
HTLV-1
KSHV (HHV-8)
MCPyV

Oncovirus guide

What they are, which viruses IARC-WHO recognizes, and why they matter.

Explore

Merkel cell polyomavirus

The virus behind a rare skin cancer, with our own research.

Explore

HPV and cervical cancer

From infection to prevention: what the scientific evidence says.

Read article

Clinical stories (ES)

HPV and EBV cases explained step by step.

View cases

Research lines

Where viruses and cancer meet

Viral carcinogenesis

Mechanisms by which HPV and Epstein-Barr virus contribute to cervical, head and neck, and lung cancers.

Viral detection in tissue

Molecular identification of oncoviruses by multiplex PCR, immunohistochemistry, CISH and in situ hybridization in clinical cohorts.

Learn more about oncoviruses

Biomarkers and cell models

Functional cell models and biomarker assays to understand the interplay between viral infection, smoking and clinical prognosis.

Want to research with us?

Research with us

Looking for scientific mentoring?

Scientific mentoring

01 — Who we are

Cutting-edge science serving clinical practice

A firm specialized in scientific and biomedical consulting that connects cutting-edge research with the real needs of health professionals, institutions and research centers, with methodological rigor and verifiable evidence.

02 — Core services

Service portfolio

Note: We do not collect samples or perform laboratory processing: we interpret molecular results already generated by a certified laboratory.

Specialized molecular interpretation

Genetic panel interpretation for oncovirus-associated cancers (HPV, EBV, MMTV-like viruses)
Molecular variant analysis in virus-related cancers
Tumor biomarkers in virally-associated cancer
Personalized scientific reports, grounded in original oncovirology research

Learn about the associated oncoviruses

Oncogenomics and precision medicine

HPV-associated cancer
EBV-associated cancer
Hereditary cancer risk
Predictive biomarkers

Institutional scientific consulting

Applied research
Technology watch
Technical opinions
Biomedical project design

Training and continuing education

Clinical genomics
Precision medicine
Molecular biomarkers
Applied bioinformatics

See each service in detail

03 — What sets us apart

Doctoral training

Evidence-based

International experience

Multidisciplinary approach

04 — Who we serve

Clinics
Hospitals
Laboratories
Universities
Fertility centers
Biotech companies
Research groups

Scientific backing

Publications and research partnerships with Universidad del Valle and the University of Tarapacá.

Universidad del Valle, Cali

Meet our strategic partners

Aguayo Lab, University of Tarapacá (Chile)

Meet our strategic partners

05 — Value model

Molecular data

Stage 1

Specialized interpretation

Stage 2

Actionable knowledge

Stage 3

Better decision-making

Stage 4

Selected publications

Have a quick question? Write to us

Leave your name, email and message and we will get back to you as soon as possible.

Vision

To be a Latin American reference in precision medicine, oncogenomics and molecular biomarkers.

Scientific rigor, evidence and clinical applicability.